Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine versus doxapram versus placebo for postoperative respiratory support after spinal surgery
IRCT20200825048515N51Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypopnea comparing Doxapram, Caffeine citrate and Placebo normal saline (3 arms). Primary endpoints: Respiratory rate, Oxygen saturation and 1 more. Started Feb 2022; status: completed.
02
Drugs
caffeinedoxapram
03
Conditions
hypopnea
Beyond the preview
Go deeper on IRCT20200825048515N51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200825048515N51.